Position in VTRS
as of Jun 30, 2026
· filed Jul 30, 2026
Position Value
$1,842
+$1,014 QoQ
Shares Held
116
+38.1% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#893
of 1,016 holders
Holding Since
Mar 2023
4 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in VTRS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Buck Wealth Strategies, LLC holds $22,720 across 10 Drug Manufacturers - Specialty & Generic names. VTRS ranks #3 (8.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TEVA |
Teva Pharmaceutical Industries Ltd
|
400 | $13,552 | |
| 2 | ZTS |
Zoetis Inc.
|
46 | $3,305 | |
| 3 | VTRS |
Viatris Inc
This page
|
116 | $1,842 | |
| 4 | AKBA |
Akebia Therapeutics, Inc.
|
1,100 | $1,254 | |
| 5 | UTHR |
UNITED THERAPEUTICS Corp
|
2 | $1,083 | |
| 6 | HLN |
Haleon plc
|
99 | $923 | |
| 7 | PRGO |
PERRIGO Co plc
|
36 | $374 | |
| 8 | ELAN |
Elanco Animal Health Inc
|
7 | $172 |
All Filings in VTRS
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,842 | 116 | Shares | Sole | 2026-07-30 | |
| 2023-09-30 | $828 | 84 | Shares | Sole | 2023-11-06 | |
| 2023-06-30 | $838 | 84 | Shares | Sole | 2023-11-06 | |
| 2023-03-31 | $808 | 84 | Shares | Sole | 2023-11-06 | |
| No filing history on record for this holder in this stock. | ||||||